Pediatric AsthmaNCT03933540
Association Between Activity and PROMIS Pediatric Measures in Children With Asthma
An observational study of Pediatric Asthma, run by Duke University at 2 sites in United States.
Trial summary
Aim: Determine the association between activity (steps taken) and PROMIS Pediatric measures in order to explore the use of pedometry data to augment PROs in research and clinical care. Read more about this study
- Who is it for?
- Ages 8 to 17 years
- Conditions the study is for
- Pediatric Asthma
- How many people
- 105 participants
- Where
- 2 sitesUnited States
- Study dates
- 15 Nov 2018to 30 Aug 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 8 to 17 years
- All sexes
- No healthy volunteers
- Child
Study population: The study sample (N=100) comprises 50 children between the ages of 8 and 12 and 50 children between the ages of 13 and 17 who have uncontrolled or partly-controlled asthma.
Who may be able to join
- Age ≥ 8 to < 18 years
- Patient meets one of the following criteria at the time of screening:
- FEV1 (Forced expiratory volume) less than 80% predicted, or
- One or more exacerbations requiring systemic steroids in the last year, or
- Partly controlled or uncontrolled asthma, using the GINA 2016 guidelines for asthma diagnosis and management
- Ability to read and understand English.
Show all 10Show fewer
- Provide informed written assent and receive informed written consent from parent.
- Ability and willingness to participate in all study activities, including completion of online surveys and wearing an activity monitor on the wrist for four weeks.
- Ability and willingness to participate in a follow up visit in the clinic/and or home 26 - 30 days after the initial clinic/and or home visit.
- Access to a smart phone, computer, tablet, or other device with internet access that is capable of supporting survey completion via the PRO-Core website.
Who cannot join
- Clinically significant cognitive or memory impairment in the opinion of clinical or research staff
- A child or adolescent who is under the legal custody of a state or a subdivision of the state.
- Comorbid conditions that could confound results such as chronic heart disease, cystic fibrosis, VCD, etc., as determined by site investigator
Trial locations and contacts
2 sites in 1 country.
United States2 sites
Boston Children's Hospital
Boston, Massachusetts, 02115
Univerity of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
About this study
Official title: Evaluating the Association Between Activity and PROMIS Pediatric Measures in Children With Chronic Conditions
Aim: Determine the association between activity (steps taken) and PROMIS Pediatric measures in order to explore the use of pedometry data to augment PROs in research and clinical care.
The investigators will evaluate the associations between activity trackers and scores on PROMIS pediatric measures in adolescents with partially controlled or uncontrolled asthma, aged 8 through 17 years. The investigators hypothesize that daily step data will be highly correlated with and responsive when measured against PROMIS Pediatric measures of Physical Activity and Physical Function-Mobility.
Read more
The Asthma (not well controlled) cohort will receive Garmin Vivofit3 activity monitors in clinic/and or home and wear them continuously for 4 weeks while completing PROMIS measures, the ecological survey, and an additional asthma control survey online (from home) via the PRO-Core data collection system at the end of each of those 4 weeks. They will return the Vivofit3 in a follow up clinic/and or home visit at the end of the 4 week period. In addition, children/adolescents will complete a spirometry test at baseline and follow up clinic/home visits. Written and verbal instructions for Vivofit3 use will be provided. Trained CRAs will communicate frequently with participants, including when the monitor is received by the participant and when the monitors need to be returned. Monitor data will be uploaded to the device user account in the Garmin Connect Mobile App by the CRA upon return of the monitor. Data from device user accounts will be imported into a UNC PRO-Core study database. Asthma participants will receive $20 at each of the two clinic/and or home visits and $10 per completed survey.
Measures and Analyses: Cross-sectional analyses of daily step and PROMIS Pediatric measures will be used to test convergent validity of conceptually linked measures. Results from regression models for longitudinal data analyses of PRO measures will be benchmarked against regression results from step data, to ascertain responsiveness. The investigators will use descriptive statistics to understand patterns by condition; the investigators will analyze data in aggregate and test whether disease group (covariate) is associated with outcomes. Analyses will control for demographics, mental health, and ecologic factors such as sports participation and season/weather.
Risk/Safety issues: This is a minimal risk study. Participants may be at risk for skin irritation due to continual monitor wear. Additionally, there is always a risk of breach of confidentiality associated with all research.
Read the detailed description
Purpose of the study:
The investigators will evaluate the associations between activity trackers and scores on PROMIS pediatric measures in adolescents with partially controlled or uncontrolled asthma, aged 8 through 17 years. The investigators hypothesize that daily step data will be highly correlated with and responsive when measured against PROMIS Pediatric measures of Physical Activity and Physical Function-Mobility.
The knowledge gained in this study could have direct clinical benefits, such as it will allow us to determine the association between steps taken (pedometer data) and PROMIS Pediatric measures in order to explore the use of pedometry data to augment PROs in future research and clinical care or to serve as a proxy measure for patients who are not able to self-report due to limitations in language, literacy, cognition or health status. Based on prior work with other PRO measures 18-20, the investigators expect that increased daily and weekly step numbers will reflect better overall health status. Pedometry may prove to be a useful proxy for health status in future research studies when adolescents are too ill to self-report using PROMIS or other traditional PROs.
Background and Significance:
Patient Reported Outcome (PRO) measures provide the opportunity to more fully gauge response to disease and therapy, providing actionable health information to take treatment to a more personalized level. For PRO measures to be widely adopted for use in either clinical trials 1 or by health care providers, there must be substantial evidence for the reliability and validity of the PRO measure in the specific population. One of the most essential aspects of the appropriateness of a PRO measure is documentation of the responsiveness of the PRO measure, which indicates the ability of the PRO measure to detect change over time when it is expected.
The PROMIS® measures represent a robust set of questionnaires for capturing the patient's experience and have undergone extensive psychometric evaluation. However, PRO measures are subjective and depend on a variety of patient level variables, including the patient's cognition, literacy, language, or health status. Additionally, some situations exist in which children or their parents may not be able to self-report symptoms using PROs due to language barriers, literacy level, or disease activity (too fatigued, etc.). Objectively reported steps, collected via pedometer wear, may be a way to augment the data that the investigators get from PRO measures and to bypass some patient level variables that can affect PRO data.
Pedometers have been shown to be suitable for assessing step activity in children age 6 years and up. A 7-day monitoring period using pedometers provided an accurate estimate of normal physical activity in children and adolescents. Prior research in children has shown correlations between physical activity and psychosocial indicators,4 physical health,5 and cognitive function6; however, there is a deficiency of knowledge related to physical activity in children with chronic illnesses, such as cancer, rheumatic disease, and asthma, association with daily steps, and impacts on health outcomes.
A review of several small pilot studies of physical activity monitoring in adult patients with cancer found physical activity, particularly the number of daily "steps", varied considerably across phases of disease and treatment type, including healthy controls, surgical resection with curative intent, and palliative chemotherapy and palliative radiation.7 Low fitness and decreased exercise capacity have been demonstrated in children with cancer,8 JIA9, 10 and SLE.11 Children with moderate to severe asthma have been shown to get less physical activity than their healthy peers.14, 15 More specifically, children with asthma tend to participate in less moderate to high intensity activity16 and to take fewer daily steps16, though there appears to be little difference in sedentary time for children with asthma and healthy controls.15, 16 However, uncertainties remain regarding the relationships between daily activity levels, disease activity, and relevant domains including physical function, pain interference, fatigue, anxiety and depression.
Design \& procedures:
This is a single arm, observational study of 100 patients with partly controlled or uncontrolled asthma. The primary purpose of this study is to determine the association between activity (steps taken) and PROMIS Pediatric measures in order to explore the use of pedometry data to augment PROs in research and clinical care. The investigators anticipate 12 months of participant accruals.
Subjects will participate in two clinic/and or home visits and complete electronic surveys from home at three time points. During the clinic/home visits on Day 0 and Day 28 (+/- 2 days), participants will complete the GINA checklist, a medication review, a spirometry test, have BMI obtained, and complete the Child Asthma Control Test (if 11 years old or younger) or the Asthma Control Test (if 12 years or older). On Day 0, parents will also complete a demographics form and the child participant will recieve their Vivofit3 monitor. The Vivofit3 will be worn 24 hours a day for 4 weeks. At Day 28, CRA's will sync the data from the Vivofit3 monitor to the participants study specific user account in the Garmin Connect Mobile app.
In between Days 0 and 28 participants will complete three sets of electronic surveys. Participants will complete their first set of surveys after 7 full days of VivoFit3 wear (study Day 7), and every 7 days after that (Study days 14, 21, and 28) by clicking on a link in the survey email that will take them to the PRO-Core data collection system. They may complete these surveys from home or anywhere they would like where they have internet access. The Day 28 survey will be completed in clinic/and or home.
The Subject Population:
The study sample (N=100) comprises 50 children between the ages of 8 and 12 and 50 children between the ages of 13 and 17 who have uncontrolled or partly-controlled asthma. The University of North Carolina (UNC) will accrue 30 children in each age group and the Boston site will accrue 20 participants in each age group. Duke is the data coordinating center for this study and will not be recruiting patients.
- Conditions
- Pediatric Asthma
- Keywords
- Patient Reported Outcome Measures, Activity Monitors, Pedometry, PROMIS, Health Measurement
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Pediatric Asthma Patients | Participants are ages 8 years through 17 years and have partially controlled or uncontrolled asthma. No intervention is included in this study. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Average daily steps
Average number of steps per day within a 1 week period, derived from Garmin VivoFit 3 activity monitor data
Measured: 1 week average, derived for each of the 4 weeks a participant wears the activity monitor for the month of study enrollment.
Secondary outcomes (7)
Self-Reported Asthma Symptoms
Patients rate their asthma symptom severity on a 6 point likert scale ranging from very bad to very good.
Measured: Weekly assessment taken at the end of each of the four study weeks.
PROMIS Pediatric Short Form v2.0 - Asthma Impact
Short form questionnaire assessing impact of asthma on daily life, 5 point likert scale responses
Measured: 7 day recall period, taken at the end of each of the four study weeks
PROMIS Pediatric Short Form v2.0 - Anxiety
Short form questionnaire assessing anxiety, 5 point likert scale responses
Measured: 7 day recall period, taken at the end of each of the four study weeks.
PROMIS Pediatric Short Form v2.0 - Depressive Symptoms
Short form questionnaire assessing depressive symptoms, 5 point likert scale responses
Measured: 7 day recall period, taken at the end of each of the four study weeks.
PROMIS Pediatric Short Form v2.0 - Fatigue
Short form questionnaire assessing fatigue, 5 point likert scale responses
Measured: 7 day recall period, taken at the end of each of the four study weeks.
PROMIS Pediatric Short Form v2.0 - Mobility
Short form questionnaire assessing mobility, 5 point likert scale responses
Measured: 7 day recall period, taken at the end of each of the four study weeks.
PROMIS Pediatric Short Form v2.0 - Peer Relationships
Short form questionnaire assessing peer relationships, 5 point likert scale responses
Measured: 7 day recall period, taken at the end of each of the four study weeks.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 May 2019
- Study start15 Nov 2018
- Primary completion30 Aug 2019
- Study completion30 Aug 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Pediatric AsthmaStudies of the same condition, open and under way.
- More trials run by Duke UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 105 participants (actual)
Sponsor and investigators
- Lead sponsor
- Duke University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Bryce Reeve, PhD, Principal investigator, Duke University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03933540
- Sponsor's protocol ID
- Pro00100297
- Status last verified
- Feb 2019
- First submitted
- 26 Apr 2019
- Last updated
- 10 Sep 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: After data collection is complete, PRO data from this project will be shared with the PEPR consortium as required by the funding mechanism for this project. All data will be deidentified and shared by the consortium through the Harvard Dataverse.
Publications
Hernandez ML, Lucas N, Mann C, Lin L, Burbank AJ, Brown J, Sims M, Ivins S, Cunningham A, Maciag MC, Akar-Ghibril N, Bennett AV, Phipatanakul W, Reeve BB. Association of step count with PROMIS pediatric health-related quality of life measures in children and adolescents with persistent asthma. J Allergy Clin Immunol Pract. 2021 Jun;9(6):2492-2494. doi: 10.1016/j.jaip.2021.01.046. Epub 2021 Feb 16. No abstract available.
PubMed 33601050
Study at a glance
From the registry record, last updated by the sponsor on 10 Sep 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluating the Association Between Activity and PROMIS Pediatric Measures in Children With Chronic Conditions
- ClinicalTrials.gov ID
- NCT03933540
- Acronym / sponsor ID
- Pro00100297
- Conditions
- Pediatric Asthma
- Keywords
- Patient Reported Outcome Measures, Activity Monitors, Pedometry, PROMIS, Health Measurement
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 105 participants (actual)
- Lead sponsor
- Duke UniversityUniversity, hospital or other
- Collaborators
- University of North Carolina, Chapel Hill, Boston Children's Hospital
- Study start
- 15 Nov 2018 (actual)
- Primary completion
- 30 Aug 2019 (actual)
- Study completion
- 30 Aug 2019 (actual)
- First posted
- 1 May 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Aim: Determine the association between activity (steps taken) and PROMIS Pediatric measures in order to explore the use of pedometry data to augment PROs in research and clinical care.
The investigators will evaluate the associations between activity trackers and scores on PROMIS pediatric measures in adolescents with partially controlled or uncontrolled asthma, aged 8 through 17 years. The investigators hypothesize that daily step data will be highly correlated with and responsive when measured against PROMIS Pediatric measures of Physical Activity and Physical Function-Mobility.
The Asthma (not well controlled) cohort will receive Garmin Vivofit3 activity monitors in clinic/and or home and wear them continuously for 4 weeks while completing PROMIS measures, the ecological survey, and an additional asthma control survey online (from home) via the PRO-Core data collection system at the end of each of those 4 weeks. They will return the Vivofit3 in a follow up clinic/and or home visit at the end of the 4 week period. In addition, children/adolescents will complete a spirometry test at baseline and follow up clinic/home visits. Written and verbal instructions for Vivofit3 use will be provided. Trained CRAs will communicate frequently with participants, including when the monitor is received by the participant and when the monitors need to be returned. Monitor data will be uploaded to the device user account in the Garmin Connect Mobile App by the CRA upon return of the monitor. Data from device user accounts will be imported into a UNC PRO-Core study database. Asthma participants will receive $20 at each of the two clinic/and or home visits and $10 per completed survey.
Measures and Analyses: Cross-sectional analyses of daily step and PROMIS Pediatric measures will be used to test convergent validity of conceptually linked measures. Results from regression models for longitudinal data analyses of PRO measures will be benchmarked against regression results from step data, to ascertain responsiveness. The investigators will use descriptive statistics to understand patterns by condition; the investigators will analyze data in aggregate and test whether disease group (covariate) is associated with outcomes. Analyses will control for demographics, mental health, and ecologic factors such as sports participation and season/weather.
Risk/Safety issues: This is a minimal risk study. Participants may be at risk for skin irritation due to continual monitor wear. Additionally, there is always a risk of breach of confidentiality associated with all research.
Detailed description
Purpose of the study:
The investigators will evaluate the associations between activity trackers and scores on PROMIS pediatric measures in adolescents with partially controlled or uncontrolled asthma, aged 8 through 17 years. The investigators hypothesize that daily step data will be highly correlated with and responsive when measured against PROMIS Pediatric measures of Physical Activity and Physical Function-Mobility.
The knowledge gained in this study could have direct clinical benefits, such as it will allow us to determine the association between steps taken (pedometer data) and PROMIS Pediatric measures in order to explore the use of pedometry data to augment PROs in future research and clinical care or to serve as a proxy measure for patients who are not able to self-report due to limitations in language, literacy, cognition or health status. Based on prior work with other PRO measures 18-20, the investigators expect that increased daily and weekly step numbers will reflect better overall health status. Pedometry may prove to be a useful proxy for health status in future research studies when adolescents are too ill to self-report using PROMIS or other traditional PROs.
Background and Significance:
Patient Reported Outcome (PRO) measures provide the opportunity to more fully gauge response to disease and therapy, providing actionable health information to take treatment to a more personalized level. For PRO measures to be widely adopted for use in either clinical trials 1 or by health care providers, there must be substantial evidence for the reliability and validity of the PRO measure in the specific population. One of the most essential aspects of the appropriateness of a PRO measure is documentation of the responsiveness of the PRO measure, which indicates the ability of the PRO measure to detect change over time when it is expected.
The PROMIS® measures represent a robust set of questionnaires for capturing the patient's experience and have undergone extensive psychometric evaluation. However, PRO measures are subjective and depend on a variety of patient level variables, including the patient's cognition, literacy, language, or health status. Additionally, some situations exist in which children or their parents may not be able to self-report symptoms using PROs due to language barriers, literacy level, or disease activity (too fatigued, etc.). Objectively reported steps, collected via pedometer wear, may be a way to augment the data that the investigators get from PRO measures and to bypass some patient level variables that can affect PRO data.
Pedometers have been shown to be suitable for assessing step activity in children age 6 years and up. A 7-day monitoring period using pedometers provided an accurate estimate of normal physical activity in children and adolescents. Prior research in children has shown correlations between physical activity and psychosocial indicators,4 physical health,5 and cognitive function6; however, there is a deficiency of knowledge related to physical activity in children with chronic illnesses, such as cancer, rheumatic disease, and asthma, association with daily steps, and impacts on health outcomes.
A review of several small pilot studies of physical activity monitoring in adult patients with cancer found physical activity, particularly the number of daily "steps", varied considerably across phases of disease and treatment type, including healthy controls, surgical resection with curative intent, and palliative chemotherapy and palliative radiation.7 Low fitness and decreased exercise capacity have been demonstrated in children with cancer,8 JIA9, 10 and SLE.11 Children with moderate to severe asthma have been shown to get less physical activity than their healthy peers.14, 15 More specifically, children with asthma tend to participate in less moderate to high intensity activity16 and to take fewer daily steps16, though there appears to be little difference in sedentary time for children with asthma and healthy controls.15, 16 However, uncertainties remain regarding the relationships between daily activity levels, disease activity, and relevant domains including physical function, pain interference, fatigue, anxiety and depression.
Design \& procedures:
This is a single arm, observational study of 100 patients with partly controlled or uncontrolled asthma. The primary purpose of this study is to determine the association between activity (steps taken) and PROMIS Pediatric measures in order to explore the use of pedometry data to augment PROs in research and clinical care. The investigators anticipate 12 months of participant accruals.
Subjects will participate in two clinic/and or home visits and complete electronic surveys from home at three time points. During the clinic/home visits on Day 0 and Day 28 (+/- 2 days), participants will complete the GINA checklist, a medication review, a spirometry test, have BMI obtained, and complete the Child Asthma Control Test (if 11 years old or younger) or the Asthma Control Test (if 12 years or older). On Day 0, parents will also complete a demographics form and the child participant will recieve their Vivofit3 monitor. The Vivofit3 will be worn 24 hours a day for 4 weeks. At Day 28, CRA's will sync the data from the Vivofit3 monitor to the participants study specific user account in the Garmin Connect Mobile app.
In between Days 0 and 28 participants will complete three sets of electronic surveys. Participants will complete their first set of surveys after 7 full days of VivoFit3 wear (study Day 7), and every 7 days after that (Study days 14, 21, and 28) by clicking on a link in the survey email that will take them to the PRO-Core data collection system. They may complete these surveys from home or anywhere they would like where they have internet access. The Day 28 survey will be completed in clinic/and or home.
The Subject Population:
The study sample (N=100) comprises 50 children between the ages of 8 and 12 and 50 children between the ages of 13 and 17 who have uncontrolled or partly-controlled asthma. The University of North Carolina (UNC) will accrue 30 children in each age group and the Boston site will accrue 20 participants in each age group. Duke is the data coordinating center for this study and will not be recruiting patients.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Pediatric Asthma Patients | – | –Participants are ages 8 years through 17 years and have partially controlled or uncontrolled asthma. No intervention is included in this study. |
Who may qualify
- Ages
- 8 to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- The study sample (N=100) comprises 50 children between the ages of 8 and 12 and 50 children between the ages of 13 and 17 who have uncontrolled or partly-controlled asthma.
Key inclusion criteria (10 listed)
- Age ≥ 8 to < 18 years
- Patient meets one of the following criteria at the time of screening:
- Ability to read and understand English.
- Provide informed written assent and receive informed written consent from parent.
- Ability and willingness to participate in all study activities, including completion of online surveys and wearing an activity monitor on the wrist for four weeks.
Key exclusion criteria (3 listed)
- Clinically significant cognitive or memory impairment in the opinion of clinical or research staff
- A child or adolescent who is under the legal custody of a state or a subdivision of the state.
- Comorbid conditions that could confound results such as chronic heart disease, cystic fibrosis, VCD, etc., as determined by site investigator
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Average daily steps
Time frame: 1 week average, derived for each of the 4 weeks a participant wears the activity monitor for the month of study enrollment.
Average number of steps per day within a 1 week period, derived from Garmin VivoFit 3 activity monitor data
7 secondary outcomes
Self-Reported Asthma Symptoms
Time frame: Weekly assessment taken at the end of each of the four study weeks.
PROMIS Pediatric Short Form v2.0 - Asthma Impact
Time frame: 7 day recall period, taken at the end of each of the four study weeks
PROMIS Pediatric Short Form v2.0 - Anxiety
Time frame: 7 day recall period, taken at the end of each of the four study weeks.
PROMIS Pediatric Short Form v2.0 - Depressive Symptoms
Time frame: 7 day recall period, taken at the end of each of the four study weeks.
PROMIS Pediatric Short Form v2.0 - Fatigue
Time frame: 7 day recall period, taken at the end of each of the four study weeks.
PROMIS Pediatric Short Form v2.0 - Mobility
Time frame: 7 day recall period, taken at the end of each of the four study weeks.
PROMIS Pediatric Short Form v2.0 - Peer Relationships
Time frame: 7 day recall period, taken at the end of each of the four study weeks.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Sep 2019.
- Derived from this study: PubMed 33601050Hernandez ML, Lucas N, Mann C, Lin L, Burbank AJ, Brown J, Sims M, Ivins S, Cunningham A, Maciag MC, Akar-Ghibril N, Bennett AV, Phipatanakul W, Reeve BB. Association of step count with PROMIS pediatric health-related quality of life measures in children and adolescents with persistent asthma. J Allergy Clin Immunol Pract. 2021 Jun;9(6):2492-2494. doi: 10.1016/j.jaip.2021.01.046. Epub 2021 Feb 16. No abstract available.
- Individual participant dataSharing planned: Yes. After data collection is complete, PRO data from this project will be shared with the PEPR consortium as required by the funding mechanism for this project. All data will be deidentified and shared by the consortium through the Harvard Dataverse.
Related trials for Pediatric Asthma
Not yet recruiting
Asthma Ctrl SMART Trial
Asthma in Children, Asthma Chronic
Not yet recruiting
Artificially Intelligent Robot Control
Asthma in Children, Artificial Intelligence
Not yet recruiting
Bilevel Positive Airway Pressure (BPAP) for Severe Asthma
Pediatric Asthma, Acute Asthma
Recruiting
Effects of Tele-rehabilitation-Guided Qigong on Children and Adolescents With Asthma
Asthma Childhood
Enrolling by invitationObservational study
Investigating Novel Strategies in Pediatric Immune Responses and Microbiome Environment: Comprehensive Lung Disease Investigation in Children.
Lung Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Bryce Reeve, PhD principal investigator
Duke University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pediatric Asthma, run by Duke University at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Average daily steps (time frame: 1 week average, derived for each of the 4 weeks a participant wears the activity monitor for the month of study enrollment.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03933540, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2019; AzTrials last refreshed its copy on 6 Nov 2026.